Yann Roche’s Post

View profile for Yann Roche, graphic

CEO & Founder, SynapCell - Innovations in CNS drug discovery - Hiring !

Accelerating  Drug Discovery in CNS Disorders

View organization page for SynapCell, graphic

3,741 followers

🌟 Accelerating  Drug Discovery in CNS Disorders 🌟 Billions are invested in drug discovery every year, yet the clinical failure rate remains dauntingly high. We understand the complexities and challenges our sponsors face in developing effective treatments for central nervous system (#CNS) disorders. 🔬 As a forerunner in the field of preclinical EEG, SynapCell benefits from unique expertise and know-how in this domain based on 20 years of experience. We offer a  comprehensive range of assays, from efficacy and derisking assays to model exploration, and ensures that drug candidates are thoroughly evaluated at every stage. Utilizing cutting-edge in vivo compound testing and EEG #biomarkers, we predict the efficacy of drug candidates early in the preclinical phase, significantly increasing the likelihood of clinical success. 🧠 Whether you are working on #epilepsy, #Parkinson’s disease or other movement disorders, #psychiatric and #neurodegenerative disorders, our translational #neuroscience expertise can guide you from discovery to successful clinical outcomes. Discover how SynapCell can revolutionize and accelerate your drug development process. Let's push the boundaries of neuroscience together! 🔗 Learn more about our services : https://synapcell.fr/ #DrugDiscovery #CNSdisorders  #PreclinicalResearch

To view or add a comment, sign in

Explore topics